White paper

Redefining Fast Melt for Pharma

Achieving high drug load with rapid dispersion using 3D printing

downloadDownload now

3DP is ushering in a new age of pharmaceutical manufacturing. And ZipDose technology, the world’s first and only FDA-validated, commercial-scale 3DP for pharma, is opening new possibilities in new therapeutic areas for drug manufacturers. With the fastest fast-melt capability available, significantly higher dosage loads and more taste masking options, the 3DP technology is clearly taking medicine “to its fullest potential.” It also enables a new world of powerful formulation solutions for NCE product candidates in Phase I or Phase II development and testing. And for manufacturers looking to extend patent exclusivity, ZipDose Technology’s new formulation capabilities also provide new pipeline potential and expanded patent opportunities to help address loss of exclusivity issues.

To download the full report, tell us a little bit about yourself.

Hmm, seems something went wrong while submitting the form. Please try again, but if the problem persists, please contact us.

3DP is ushering in a new age of pharmaceutical manufacturing. And ZipDose technology, the world’s first and only FDA-validated, commercial-scale 3DP for pharma, is opening new possibilities in new therapeutic areas for drug manufacturers. With the fastest fast-melt capability available, significantly higher dosage loads and more taste masking options, the 3DP technology is clearly taking medicine “to its fullest potential.” It also enables a new world of powerful formulation solutions for NCE product candidates in Phase I or Phase II development and testing. And for manufacturers looking to extend patent exclusivity, ZipDose Technology’s new formulation capabilities also provide new pipeline potential and expanded patent opportunities to help address loss of exclusivity issues.

Download now